Swedbank’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.7M | Buy |
431,943
+2,100
| +0.5% | +$115K | 0.03% | 333 |
|
|
2025
Q1 | $30.4M | Sell |
429,843
-2,279
| -0.5% | -$161K | 0.04% | 282 |
|
|
2024
Q4 | $28.4M | Buy |
432,122
+43,593
| +11% | +$2.87M | 0.03% | 289 |
|
|
2024
Q3 | $27.3M | Buy |
388,529
+100,000
| +35% | +$7.03M | 0.03% | 286 |
|
|
2024
Q2 | $23.8M | Sell |
288,529
-7,600
| -3% | -$626K | 0.03% | 290 |
|
|
2024
Q1 | $25.9M | Sell |
296,129
-170,100
| -36% | -$14.9M | 0.23% | 148 |
|
|
2023
Q4 | $45M | Sell |
466,229
-40,800
| -8% | -$3.93M | 0.07% | 192 |
|
|
2023
Q3 | $44.9M | Hold |
507,029
| – | – | 0.08% | 182 |
|
|
2023
Q2 | $43.9M | Hold |
507,029
| – | – | 0.07% | 198 |
|
|
2023
Q1 | $49.3M | Buy |
507,029
+59,200
| +13% | +$5.76M | 0.1% | 172 |
|
|
2022
Q4 | $46.3M | Buy |
447,829
+26,900
| +6% | +$2.78M | 0.1% | 184 |
|
|
2022
Q3 | $35.7M | Sell |
420,929
-108,190
| -20% | -$9.17M | 0.08% | 197 |
|
|
2022
Q2 | $43.8M | Buy |
529,119
+24,661
| +5% | +$2.04M | 0.1% | 182 |
|
|
2022
Q1 | $38.9M | Buy |
504,458
+183,493
| +57% | +$14.1M | 0.07% | 226 |
|
|
2021
Q4 | $28.6M | Sell |
320,965
-15,058
| -4% | -$1.34M | 0.05% | 277 |
|
|
2021
Q3 | $26M | Buy |
336,023
+192,144
| +134% | +$14.9M | 0.05% | 288 |
|
|
2021
Q2 | $12M | Hold |
143,879
| – | – | 0.02% | 446 |
|
|
2021
Q1 | $10.9M | Buy |
+143,879
| New | +$10.9M | 0.02% | 451 |
|